Skip to main content
. 2013 Jun 6;97(8):989–993. doi: 10.1136/bjophthalmol-2012-303040

Table 2.

Mean±SD change from baseline in worse eye intraocular pressure (mm Hg), per-protocol population

Visit Time point Bimatoprost PF (N=295) Bimatoprost (N=291) Bimatoprost PF−bimatoprost difference (95% CI)
Baseline 8:00 24.90±2.36 24.86±2.16 0.04 (−0.31, 0.39)
  N 295 291  
  10:00 23.79±2.99 23.78±2.75 0.05 (−0.39, 0.50)
  N 291 288  
  16:00 22.81±3.17 22.80±3.30 0.04 (−0.44, 0.53)
  N 294 290  
Week 2 8:00 −7.22±2.84 −7.55±2.97 0.37 (−0.05, 0.78)
  N 283 281  
  10:00 −6.85±3.22 −7.17±2.92 0.31 (−0.10, 0.72)
  N 282 279  
  16:00 −6.03±3.16 −6.27±3.40 0.25 (−0.15, 0.64)
  N 283 280  
Week 6 8:00 −7.43±2.78 −7.58±3.09 0.14 (−0.30, 0.58)
  N 276 277  
  10:00 −7.01±3.06 −7.14±3.12 0.10 (−0.33, 0.52)
  N 275 276  
  16:00 −6.02±3.29 −6.34±3.41 0.26 (−0.15, 0.68)
  N 276 277  
Week 12 8:00 −7.49±2.90 −7.77±3.03 0.32 (−0.12, 0.75)
  N 281 274  
  10:00 −7.06±3.33 −7.11±3.19 0.02 (−0.42, 0.45)
  N 279 272  
  4:00 −5.93±3.43 −6.06±3.60 0.13 (−0.29, 0.55)
  N 279 272  

PF, preservative-free.